Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Meeuwes FO"'
Autor:
Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Huisman F; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Hematology, Treant Hospital, Emmen, The Netherlands., Meeuwes FO; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Hematology, Treant Hospital, Emmen, The Netherlands., van der Poel MWM; Division of Hematology, Department of Interne Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Böhmer L; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle, The Netherlands., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Diepstra A; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., Huls G; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2024 Jul 23; Vol. 8 (14), pp. 3619-3628.
Autor:
Meeuwes FO; Department of Hematology, Treant Hospital, Emmen, The Netherlands; Department of Hematology, University Medical Center Groningen, Groningen., Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht., Plattel W; Department of Hematology, University Medical Center Groningen, Groningen., Van der Poel MWM; Department of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam., Böhmer L; Department of Hematology, Haga Hospital, The Hague., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden., Neelis KJ; Department of Radiotherapy, Leiden University Medical Center, Leiden., Crijns APG; Department of Radiotherapy, University Medical Center Groningen, Groningen., Daniëls LA; Department of Radiotherapy, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden., Huls GA; Department of Hematology, University Medical Center Groningen, Groningen., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen. m.nijland@umcg.nl.
Publikováno v:
Haematologica [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1163-1170. Date of Electronic Publication: 2024 Apr 01.
Autor:
Meeuwes FO; Department of Hematology, Treant Hospital, Emmen, the Netherlands; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Böhmer L; Department of Hematology, Haga Hospital, The Hague, the Netherlands., Woei-A-Jin S; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle, the Netherlands., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Diepstra A; Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Huls GA; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.nijland@umcg.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 176, pp. 100-109. Date of Electronic Publication: 2022 Oct 05.
Autor:
Al-Sarayfi D; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Meeuwes FO; Department of Hematology, Treant Hospital, Emmen, The Netherlands., Durmaz M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Issa DE; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands., Brouwer RE; Department of Internal Medicine, Reinier de Graaf Gasthuis, Delft, The Netherlands., Beeker A; Department of Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands., van Rhenen A; Department of Hematology, Cancer Center, UMC Utrecht, Utrecht, The Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Böhmer LH; Department of Hematology, Haga Teaching Hospital, The Hague, The Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Te Boome L; Department of Hematology, Haaglanden Medical Center, The Hague, The Netherlands., van Meerten T; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Chamuleau MED; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Zijlstra JM; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands. m.nijland@umcg.nl.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2022 Sep 02; Vol. 12 (9), pp. 125. Date of Electronic Publication: 2022 Sep 02.
Autor:
Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Meeuwes FO; Department of Hematology, Martini Hospital, Groningen, The Netherlands.; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., van der Poel MWM; Division of Hematology, Department of Internal Medicine, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Wondergem M; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Böhmer LH; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle, The Netherlands., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands; and., Jansen PM; Department of Pathology and., Plattel W; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Huls GA; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
Publikováno v:
Blood [Blood] 2022 Sep 01; Vol. 140 (9), pp. 1009-1019.
Autor:
Al-Sarayfi D; Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands., Meeuwes FO; Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.; Department of Hematology, Martini Hospital, Groningen, The Netherlands., Munnink TO; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands., Plattel W; Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands., Rosati S; Department of Pathology, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands., Matutes E; Department of Hematopathology, Hospital Clínic, Barcelona, Spain., Nijland M; Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. m.nijland@umcg.nl.
Publikováno v:
Annals of hematology [Ann Hematol] 2022 Mar; Vol. 101 (3), pp. 703-704. Date of Electronic Publication: 2021 Jun 04.
Autor:
Meeuwes FO; 1Department of Internal Medicine, Isala, Zwolle, the Netherlands., Perton F, Dutilh JC
Publikováno v:
The Netherlands journal of medicine [Neth J Med] 2017 Apr; Vol. 75 (3), pp. 127.
Autor:
Meeuwes FO; Departments of Internal Medicine, Intensive Care Medicine, Isala, Zwolle, the Netherlands., Hukshorn CJ, Bloembergen P
Publikováno v:
The Netherlands journal of medicine [Neth J Med] 2015 Oct; Vol. 73 (8), pp. 392-3.